Skip to main content
OpenTrials

Clinical trial condition

Hemochromatosis, Type 4

Explore clinical trials studying Hemochromatosis, Type 4. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Hemochromatosis, Type 4 trial results

Completed

Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.

NCT01949467

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diagnosis, Disease, +15 more
Locations
  • CHU Clermont-Ferrand Clermont-Ferrand, France
  • CHU Limoges Limoges, France
  • CHU Montpellier Montpellier, France
  • CHU Pontchaillou Rennes, France
View Trial Details

Related conditions